EGFR and lung adenocarcinoma: Our study showed that TLGWBR (TLGWBR ≥259.85), EGFR mutation status, and serum LDH level for baseline 18F-FDG PET/CT were significant independent prognostic factors for PFS and OS in 176 patients with advanced lung adenocarcinoma.